Stockscreener 앱 받기
11.34
5.59%
0.60
시간 외 거래:
11.26
-0.08
-0.71%
전일 마감가:
$10.74
열려 있는:
$10.69
하루 거래량:
63,660
Relative Volume:
0.68
시가총액:
$60.68M
수익:
$7.97M
순이익/손실:
$-75.74M
주가수익비율:
-0.4669
EPS:
-24.2853
순현금흐름:
$-85.33M
1주 성능:
+7.49%
1개월 성능:
+43.36%
6개월 성능:
-21.25%
1년 성능:
-5.03%
1일 변동 폭
$10.48
$11.43
1주일 범위
$10.01
$11.43
52주 변동 폭
$3.76
$46.80
Aligos Therapeutics Inc Stock (ALGS) Company Profile
명칭
Aligos Therapeutics Inc
전화
(800) 466-6059
주소
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
ALGS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALGS
Aligos Therapeutics Inc
|
11.34 | 74.66M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-18 | 재개 | H.C. Wainwright | Buy |
| 2024-08-19 | 개시 | H.C. Wainwright | Buy |
| 2023-01-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-01-06 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-03-23 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-01-06 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-09-09 | 개시 | SVB Leerink | Outperform |
| 2021-05-17 | 재개 | Piper Sandler | Overweight |
| 2020-11-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-10 | 개시 | JP Morgan | Overweight |
| 2020-11-10 | 개시 | Jefferies | Buy |
| 2020-11-10 | 개시 | Piper Sandler | Overweight |
모두보기
Aligos Therapeutics Inc 주식(ALGS)의 최신 뉴스
Will Aligos Therapeutics Inc. bounce back from current support2025 Sector Review & Real-Time Buy Signal Notifications - Newser
Aug Macro: What is the target price for Aligos Therapeutics Inc. stockJuly 2025 Update & Advanced Swing Trade Entry Alerts - خودرو بانک
Is Aligos Therapeutics Inc. stock undervalued right now2025 Market Trends & Fast Gaining Stock Strategy Reports - خودرو بانک
What does recent volatility data suggest for Aligos Therapeutics Inc.Trade Entry Report & Free Daily Entry Point Trade Alerts - Newser
Will Aligos Therapeutics Inc. benefit from geopolitical trendsEarnings Performance Report & High Conviction Trade Alerts - خودرو بانک
Will Aligos Therapeutics Inc. outperform the marketJuly 2025 Update & Short-Term Trading Opportunity Alerts - Newser
Aligos Therapeutics Inc. stock trend outlook and recovery pathEarnings Overview Summary & Advanced Technical Signal Analysis - Newser
Will Aligos Therapeutics Inc. price bounce be sustainableGap Up & Verified Entry Point Signals - Newser
Aligos Therapeutics Inc. stock trendline breakdownEarnings Beat & Stock Portfolio Risk Control - Newser
Can you recover from losses in Aligos Therapeutics Inc.Trade Risk Report & AI Enhanced Trade Execution Alerts - Newser
What’s next for Aligos Therapeutics Inc. stock price2025 Geopolitical Influence & Consistent Profit Trade Alerts - Newser
What data driven models say about Aligos Therapeutics Inc.’s futureJuly 2025 Catalysts & Weekly Chart Analysis and Guides - Newser
Candlestick signals on Aligos Therapeutics Inc. stock today2025 Biggest Moves & Community Trade Idea Sharing Platform - Newser
Short interest data insights for Aligos Therapeutics Inc.Weekly Trend Report & AI Enhanced Execution Alerts - Newser
Is Aligos Therapeutics Inc. meeting your algorithmic filter criteriaWeekly Trade Report & Community Verified Trade Alerts - Newser
Combining price and volume data for Aligos Therapeutics Inc.Weekly Profit Report & Weekly Consistent Profit Watchlists - Newser
News impact scoring models applied to Aligos Therapeutics Inc.Market Risk Summary & Expert Verified Movement Alerts - Newser
How to monitor Aligos Therapeutics Inc. with trend dashboardsEarnings Overview Summary & Expert Approved Momentum Ideas - Newser
Smart tools for monitoring Aligos Therapeutics Inc.’s price actionQuarterly Profit Report & Free Technical Confirmation Trade Alerts - Newser
Will Aligos Therapeutics Inc. continue its uptrendMarket Risk Analysis & Weekly Watchlist of Top Performers - Newser
Real time breakdown of Aligos Therapeutics Inc. stock performance2025 Big Picture & Long-Term Capital Growth Ideas - Newser
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting - The Manila Times
Aligos Therapeutics Announces Six Preclinical Presentations at 2025 International HBV Meeting: Novel Approaches and Molecular Strategies to Advance Liver and Viral Diseases. - AInvest
Breakthrough HBV Drug Shows Direct cccDNA Reduction: Aligos Therapeutics Unveils Game-Changing Results - Stock Titan
Aligos Therapeutics describes new PD-1/PD-L1 interaction inhibitors - BioWorld MedTech
Aligos Therapeutics Inc.’s volatility index tracking explainedMarket Activity Recap & Real-Time Volume Analysis - Newser
Is Aligos Therapeutics Inc. stock heavily shortedJuly 2025 Final Week & Stock Market Timing Techniques - خودرو بانک
Analyzing Aligos Therapeutics (NASDAQ:ALGS) & Amarin (NASDAQ:AMRN) - Defense World
What chart patterns are forming on Aligos Therapeutics Inc.Quarterly Portfolio Report & AI Enhanced Trading Alerts - خودرو بانک
Intraday pattern recognizer results for Aligos Therapeutics Inc.2025 Trading Recap & Growth Focused Entry Reports - Newser
Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
Clinical-Stage Liver Disease Developer Aligos Therapeutics to Share Updates at Global Investment Conference - Stock Titan
Can a trend reversal in Aligos Therapeutics Inc. lead to recoveryQuarterly Profit Review & Real-Time Stock Entry Alerts - Newser
Risk vs reward if holding onto Aligos Therapeutics Inc.2025 Price Action Summary & Long-Term Growth Plans - Newser
Heatmap analysis for Aligos Therapeutics Inc. and competitorsMarket Growth Report & Smart Allocation Stock Tips - Newser
Is Aligos Therapeutics Inc.’s ROE strong enoughQuarterly Profit Summary & Safe Entry Momentum Stock Tips - خودرو بانک
What’s the fair value of Aligos Therapeutics Inc. stockJuly 2025 Rallies & Stock Market Timing Techniques - خودرو بانک
Aligos Therapeutics Inc (ALGS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):